Impact News +++ PagerDuty, Halliburton rise; Marvell Technology, Yext fall (AP) +++ YEXT Aktie -5,67%

ACORDA Aktie

 >ACORDA Aktienkurs 
0.65 EUR    -0.8%    (Tradegate)
Ask: 0.66 EUR / 2268 Stück
Bid: 0.65 EUR / 2338 Stück
Tagesumsatz: 1100 Stück
Realtime Kurs von 8 bis 22 Uhr!
>ACORDA Performance
1 Woche: +7,5%
1 Monat: -20,4%
3 Monate: +55,0%
6 Monate: -3,7%
1 Jahr: -65,6%
laufendes Jahr: -72,4%
>ACORDA Aktie
Name:  ACORDA THERAP.CDT DL-,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US00484M1062 / A0BK80
Symbol/ Ticker:  CDG (Frankfurt) / ACOR (NASDAQ)
Kürzel:  FRA:CDG, CDG.F, CDG:GR, NASDAQ:ACOR
Index:  -
Webseite:  http://www.acorda.com/
Marktkapitalisierung:  26.76 Mio. EUR
Umsatz:  136.11 Mio. EUR
EBITDA:  -33.63 Mio. EUR
Gewinn je Aktie:  0.841 EUR
Schulden:  211.03 Mio. EUR
Liquide Mittel:  52.09 Mio. EUR
Umsatz-/ Gewinnwachstum:  11.20% / -
KGV/ KGV lG:  0.67 / -
KUV/ KBV/ PEG:  0.2 / 0.11 / -
Gewinnm./ Eigenkapitalr.:  29.71% / 16.51%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  ACORDA
Letzte Datenerhebung:  05.12.20
>ACORDA Eigentümer
Aktien: 56.87 Mio. St.
f.h. Aktien: 43.26 Mio. St.
Insider Eigner: 1.69%
Instit. Eigner: 50.88%
Leerverk. Aktien: 12.82%
>ACORDA Peer Group

 
03.12.20 - 15:49
Implied Volatility Surging for Acorda (ACOR) Stock Options (Zacks)
 
Investors need to pay close attention to Acorda (ACOR) stock based on the movements in the options market lately....
05.11.20 - 20:58
Acorda Therapeutics, Inc. 2020 Q3 - Results - Earnings Call Presentation (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.11.20 - 02:16
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2020 Results - Earnings Call Transcript (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.11.20 - 00:02
Acorda Therapeutics (ACOR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
 
Acorda (ACOR) delivered earnings and revenue surprises of 23.33% and 80.64%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?...
03.11.20 - 22:22
Acorda Therapeutics: Q3 Earnings Insights (Benzinga)
 
Shares of Acorda Therapeutics (NASDAQ:ACOR) increased 8.33% after the company reported Q3 results. Quarterly Results Earnings per share rose 50.00% over the past year to ($0.23), which beat the estimate of ($0.31). read more...
03.11.20 - 22:07
Acorda Therapeutics EPS beats by $0.10, beats on revenue (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.11.20 - 22:07
Acorda Therapeutics EPS beats by $0.07, beats on revenue (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.11.20 - 22:01
Acorda Reports Third Quarter 2020 Financial Results (Business Wire EN)
 
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ:ACOR) today reported its financial results for the third quarter ended September 30, 2020. “We are encouraged by the 24% increase in INBRIJA net sales over the second quarter, even w...
27.10.20 - 12:07
Acorda Third Quarter 2020 Update: Webcast/Conference Call Scheduled for November 3, 2020 (Business Wire EN)
 
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its third quarter 2020 update and financial results on Tuesday, November 3 at 4:30 p.m. ET. To participate in the Web...
26.10.20 - 18:31
Acorda Therapeutics (ACOR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
 
Acorda (ACOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
20.10.20 - 17:25
Why Acorda′s Stock Is Trading Higher Today (Benzinga)
 
Acorda Therapeutics (NASDAQ: ACOR) shares are trading higher on Tuesday after the company announced it has become entitled to receive a $15 million milestone payment from Biogen. read more...
20.10.20 - 16:01
Looking Into Acorda Therapeutics′s Return On Capital Employed (Benzinga)
 
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 sales of $33.62 million. Earnings fell to a loss of $18.48 million, resulting in a 43.49% decrease from last quarter. Acorda Therapeutics collected $28.10 million in revenue during Q1, but reported earni...
20.10.20 - 15:36
Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices? (PR Newswire)
 
NEW YORK , Oct. 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APTX, ACOR, TMUS, BBY, and AMD....
20.10.20 - 15:10
Acorda Therapeutic to receive $15M milestone payment from Biogen (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.09.20 - 18:02
Are Options Traders Betting on a Big Move in Acorda Therapeutics (ACOR) Stock? (Zacks)
 
Investors need to pay close attention to Acorda Therapeutics (ACOR) stock based on the movements in the options market lately....
>Zitat des Tages: Die Frucht wird durch den Glauben bezwungen. - Martin Luther King jr.
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!